Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Vaccines

Free Subscription 24.08.2020 2 Ann Intern Med 1 Arch Virol 4 BMJ 1 J Infect 2 J Infect Dis 5 JAMA 1 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 5 N Engl J Med 1 PLoS Med 6 PLoS One 10 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. DONZELLI A
   Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality.
   Ann Intern Med. 2020;173:322.
   PubMed        
   
   
2. ANDERSON ML, Dobkin C, Gorry D
   Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality.
   Ann Intern Med. 2020;173:322-323.
   PubMed        
   
   

   
   Arch Virol

3. LAHER F, Bekker LG, Garrett N, Lazarus EM, et al
   Review of preventative HIV vaccine clinical trials in South Africa.
   Arch Virol. 2020 Aug 14. pii: 10.1007/s00705-020-04777.
   PubMed         Abstract available
   
   

   
   BMJ

4. MATHEW R
   Rammya Mathew: Planning for this year's flu vaccination programme.
   BMJ. 2020;370:m3180.
   PubMed        
   
   
5. TORREELE E
   The rush to create a covid-19 vaccine may do more harm than good.
   BMJ. 2020;370:m3209.
   PubMed        
   
   
6. MAHASE E
   Covid-19: Russia approves vaccine without large scale testing or published results.
   BMJ. 2020;370:m3205.
   PubMed        
   
   
7. TORJESEN I
   Covid-19: Pre-purchasing vaccine-sensible or selfish?
   BMJ. 2020;370:m3226.
   PubMed        
   
   

   
   J Infect

8. KINOSHITA M, Tanaka M
   Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
   J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
   PubMed         Abstract available
   
   

   
   J Infect Dis

9. SALEEM AF, Mach O, Yousafzai MT, Kazi Z, et al
   One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine.
   J Infect Dis. 2020 Aug 15. pii: 5892949. doi: 10.1093.
   PubMed         Abstract available
   
   
10. BEALL B, Walker H, Tran T, Li Z, et al
    Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico.
    J Infect Dis. 2020 Aug 15. pii: 5892947. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JAMA

11. SOLOMON DA
    Seasonal Influenza Vaccination.
    JAMA. 2020 Aug 14. pii: 2769679. doi: 10.1001/jama.2020.14772.
    PubMed        
    
    
12. PHADKE VK, Bednarczyk RA, Omer SB
    Vaccine Refusal and Measles Outbreaks in the US.
    JAMA. 2020 Aug 14. pii: 2769677. doi: 10.1001/jama.2020.14828.
    PubMed        
    
    
13. WANG EA, Zenilman J, Brinkley-Rubinstein L
    Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    JAMA. 2020 Aug 17. pii: 2769694. doi: 10.1001/jama.2020.15589.
    PubMed        
    
    
14. GROHSKOPF LA, Liburd LC, Redfield RR
    Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic.
    JAMA. 2020 Aug 20. pii: 2769837. doi: 10.1001/jama.2020.15845.
    PubMed        
    
    
15. JAKLEVIC MC
    Flu Vaccination Urged During COVID-19 Pandemic.
    JAMA. 2020 Aug 20. pii: 2769836. doi: 10.1001/jama.2020.15444.
    PubMed        
    
    

    
    Lancet Infect Dis

16. HEATH PT, Le Doare K, Khalil A
    Inclusion of pregnant women in COVID-19 vaccine development.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30638.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

17. ELAM-EVANS LD, Yankey D, Singleton JA, Sterrett N, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:1109-1116.
    PubMed         Abstract available
    
    

    
    N Engl J Med

18. LOW JG, Ng JHJ, Ong EZ, Kalimuddin S, et al
    Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody.
    N Engl J Med. 2020;383:452-459.
    PubMed         Abstract available
    
    
19. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Building a Successful Public Health Response to Covid-19.
    N Engl J Med. 2020;383:e67.
    PubMed        
    
    
20. SCHACHAR RA, Schachar IH
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        
    
    
21. SCHAEFER JR, Sharkova Y, Nickolaus T
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        
    
    
22. JACKSON LA, Roberts PC, Graham BS
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.
    N Engl J Med. 2020;383.
    PubMed        
    
    

    
    PLoS Med

23. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    PubMed         Abstract available
    
    

    
    PLoS One

24. URABE CT, Tanaka G, Oshima T, Maruyama A, et al
    Comparing catch-up vaccination programs based on analysis of 2012-13 rubella outbreak in Kawasaki City, Japan.
    PLoS One. 2020;15:e0237312.
    PubMed         Abstract available
    
    
25. HASAN M, Azim KF, Imran MAS, Chowdhury IM, et al
    Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach.
    PLoS One. 2020;15:e0237181.
    PubMed         Abstract available
    
    
26. PARKINSON LV, Mulder CPH
    Patterns of pollen and resource limitation of fruit production in Vaccinium uliginosum and V. vitis-idaea in Interior Alaska.
    PLoS One. 2020;15:e0224056.
    PubMed         Abstract available
    
    
27. LI AJ, Tabu C, Shendale S, Sergon K, et al
    Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
    PLoS One. 2020;15:e0237913.
    PubMed         Abstract available
    
    
28. BARAL R, Fleming J, Khan S, Higgins D, et al
    Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage.
    PLoS One. 2020;15:e0237718.
    PubMed         Abstract available
    
    
29. FISHER BS, Dambrauskas N, Trakhimets O, Andrade DV, et al
    Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates.
    PLoS One. 2020;15:e0233577.
    PubMed         Abstract available
    
    

    
    Vaccine

30. YITBAREK K, Abraham G, Girma T, Tilahun T, et al
    The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31049.
    PubMed         Abstract available
    
    
31. HUNG MC, Lu PJ, Srivastav A, Cheng YJ, et al
    Influenza vaccination coverage among adults with diabetes, United States, 2007-08 through 2017-18 seasons.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31029.
    PubMed         Abstract available
    
    
32. NEWMAN KL, Stewart LM, Scott EM, Tielsch JM, et al
    Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31045.
    PubMed         Abstract available
    
    
33. BRUCE MG, Meites E, Bulkow L, Panicker G, et al
    A prospective cohort study of immunogenicity of quadrivalent human papillomavirus vaccination among Alaska Native Children, Alaska, United States.
    Vaccine. 2020 Aug 16. pii: S0264-410X(20)31026.
    PubMed         Abstract available
    
    
34. BECK E, Klint J, Garcia S, Abbing V, et al
    Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
    Vaccine. 2020 Aug 14. pii: S0264-410X(20)31028.
    PubMed         Abstract available
    
    
35. VON LINSTOW ML, Nordmann Winther T, Eltvedt A, Bybeck Nielsen A, et al
    Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31031.
    PubMed         Abstract available
    
    
36. BENNETT N, Crouch S, Hoskins A, Malloy MJ, et al
    'Closing the gap': Evaluating the success of non-mandatory strategies for influenza vaccination of Victorian healthcare workers.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31044.
    PubMed         Abstract available
    
    
37. CONTRERAS M, San Jose C, Estrada-Pena A, Talavera V, et al
    Control of tick infestations in wild roe deer (Capreolus capreolus) vaccinated with the Q38 Subolesin/Akirin chimera.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31004.
    PubMed         Abstract available
    
    
38. BALASUBRAMANI GK, Choi WS, Nowalk MP, Zimmerman RK, et al
    Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31032.
    PubMed         Abstract available
    
    
39. WOLDEYOHANNES SM, Perkins NR, Baker P, Gilks CF, et al
    Q fever vaccine efficacy and occupational exposure risk in Queensland, Australia: A retrospective cohort study.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31027.
    PubMed         Abstract available
    
    

    
    Virology

40. IN HJ, Lee YH, Jang S, Lim HJ, et al
    Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine.
    Virology. 2020;549:25-31.
    PubMed         Abstract available
    
    

    
    Virus Res

41. KAUR SP, Gupta V
    COVID-19 Vaccine: A comprehensive status report.
    Virus Res. 2020 Aug 12:198114. doi: 10.1016/j.virusres.2020.198114.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: